RESI Asia Japan 2027

Created in partnership with the Kobe Biomedical Innovation Cluster (KBIC), RESI Asia Japan is the gateway connecting early-stage life science companies with Japan’s leading pharmaceutical giants and global capital. Following RESI Boston and RESI JPM, this premiere event completes a 7-month global partnering cycle, offering fundraising startups unparalleled access to licensing deals, cross-border investment syndicates, and Asia’s largest life science market.